Synergen Inc said it plans tofile with the Securities and Exchange Commission to sell about1.5 mln shares of common stock.    Proceeds would be used to fund research and development,for product testing, working capital and general purposes.    The offering will be made through underwriters and only bymeans of a prospectus, the biotechnology firm said. Reuter&#3;